Activation of cardiac M 3 muscarinic acetylcholine receptors has cardioprotective effects against ischaemia-induced arrhythmias

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 4, 2012, Pages 343-349

  Wang, Shu ^a,b   Han, Hong Mei ^a,b   Jiang, Ya Nan ^a   Wang, Chao ^a   Song, Hao Xin ^a   Pan, Zhen Yu ^a   Fan, Kai ^a   Du, Juan ^a   Fan, Yu Hua ^a   Du, Zhi Min ^a   Liu, Yan ^a  

^a Department of Pharmacology   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Ca 2+; Cardiac M 3 muscarinic acetylcholine receptors; Ischaemic arrhythmias; Na + Ca 2+ exchanger (NCX)

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; CALCIUM CHANNEL L TYPE; CHOLINE; MESSENGER RNA; MUSCARINIC M3 RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN; CARDIOTONIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ISOLATION; CONTROLLED STUDY; GENE EXPRESSION; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MUSCLE CELL; NONHUMAN; PH; PROTEIN BLOOD LEVEL; RAT; ANIMAL; COMPARATIVE STUDY; DRUG POTENTIATION; METABOLISM; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOTONIC AGENTS; CHOLINE; MALE; MYOCARDIAL ISCHEMIA; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M3; TREATMENT OUTCOME;

EID: 84858974829     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05672.x     Document Type: Article

References (32)

1. + channel. J. Membr. Biol. 1999; 169: 55-64.
2. + channel. J. Biol. Chem. 2004; 279: 21774-8.
3. + current. Br. J. Pharmacol. 1999; 126: 1725-34.
4. 3 - a new target of antiarrhythmic agents. Acta Pharmacol. Sin. 2005; 40: 8-12.
5. 3 receptor and myocyte apoptosis induced by acute myocardial infarction. Acta Pharmacol. Sin. 2004; 39: 338-41.
6. 3 receptors. J. Auton. Pharmacol. 2007; 27: 1-11.
7. Bers DM. Cardiac excitation-contraction coupling. Nature 2001; 415: 198-205.
8. Qian YW, Clusin WT, Lin SF, Han J, Sung RJ. Spatial heterogeneity of calcium transient alternans during the early phase of myocardial ischemia in the blood-perfused rabbit heart. Circulation 2001; 104: 2082-7.
9. Lakkireddy V, Bub G, Baweja P, Syed A, Boutjdir M, El-Sherif N. The kinetics of spontaneous calcium oscillations and arrhythmogenesis in the in vivo heart during ischemia/reperfusion. Heart Rhythm 2006; 3: 58-66.
10. Zhang Y, Liu Y, Wang T et al. Resveratrol, a natural ingredient of grape skin: Antiarrhythmic efficacy and ionic mechanisms. Biochem. Biophys. Res. Commun. 2006; 340: 1192-9.
11. 3 receptor in aconitine/bariumchloride-induced preconditioning against arrhythmias in rats. Naunyn Schmiedebergs Arch. Pharmacol. 2009; 379: 511-15.
12. 2α on aconitine-induced cardiac arrhythmia in rats. Prostaglandins 1979; 18: 235-8.
13. 2+ transient in rat ventricular myocytes. Circ. Res. 2002; 91: 585-93.
14. 2+ sparks triggered by patch depolarization in rat heart cells. Circ. Res. 1998; 82: 424-9.
15. Coetzee WA, Opie LH. Effects of components of ischemia and metabolic inhibition on delayed after depolarizations in guinea pig papillary muscle. Circ. Res. 1987; 61: 157-65.
16. 3 pathway. Basic Clin. Pharmacol. Toxicol. 2006; 98: 104-9.
17. Sun LJ, Du J, Zhang G et al. Aberration of L-type calcium channel in cardiac myocytes is one of the mechanisms of arrhythmia induced by cerebral ischemia. Cell. Physiol. Biochem. 2008; 22: 147-56.
18. 2+ handling and myofilament desensitization underlie cardiomyocyte performance in normothermic and hyperthermic heat-acclimated rat hearts. J. Appl. Physiol. 2007; 103: 266-75.
19. Yang B, Lin H, Xu C, Liu Y, Wang H, Wang Z. Choline produces cytoprotective effects against ischemic myocardiac injuries. Evidence for the role of cardiac M3 subtype muscarinic acetylcholine receptors. Cell. Physiol. Biochem. 2005; 16: 163-74.
20. 2+ release channel ryanodine receptor (RyR2) plays a crucial role in aconitine-induced arrhythmias. Biochem. Pharmacol. 2008; 75: 2147-56.
21. Podzuweit T. Cyclic AMP arrhythmias. Inhibition by choline esters. Adv. Myocardiol. 1982; 3: 193-8.
22. Piacentino V III, Weber CR, Chen X et al. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res. 2003; 92: 651-8.
23. 2+-ATPase overexpression in postinfarction rat myocytes. J. Appl. Physiol. 2005; 98: 2169-76.
24. 2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: Evidence for a sequential mechanism in ryanodine action. Mol. Pharmacol. 1991; 39: 679-89.
25. 2+ exchanger confers protection against ischemia/reperfusion injury. Circ. Res. 2005; 97: 916-21.
26. +. Cardiovasc. Res. 1999; 41: 175-87.
27. 2+ exchange. Circ. Res. 1992; 71: 547-57.
28. + exchange in ischemia-reperfusion. Basic Res. Cardiol. 1996; 91: 191-202.
29. Levitsky J, Gurell D, Frishman WH. Sodium ion/hydrogen ion exchange inhibition: A new pharmacologic approach to myocardial ischemia and reperfusion injury. J. Clin. Pharmacol. 1998; 38: 887-97.
30. 2+ exchanger. Am. J. Physiol. 1999; 276: H1868-76.
31. 2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc. Res. 2001; 51: 241-50.
32. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ. Res. 1991; 68: 1250-8.